PTCT PTC Therapeutics, Inc. - Common Stock
$70,61
Fiyat · Ağu 21, 2026
Temel veriler itibarıyla Tem 30, 2026
52 Haftlık Aralık
$48–$91
52% of range
Analist Derecelendirmesi
BUY
21 analysts
Fiyat Hedefi
$99
+41% upside
P/E (TTM)
9.1
ROE
-331.5%
Net Kâr Marjı
39.4%
PTC Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Devamını oku
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.
Products
In 2017, PTC acquired Emflaza (deflazacort) from Marathon Pharmaceuticals. PTC also owns Translarna, (Ataluren) marketed for nonsense mutation Duchenne muscular dystrophy. Together, the two products generated revenues of 174 million dollars and 260 million dollars in 2017 and 2018 respectively.
PTC has the commercialization rights for WAYLIVRA (volanesorsen) in Latin America.
In 2018, PTC acquired Agilis Biotherapeutics and a gene therapy candidate, GT-AADC, with its compelling clinical data in treating aromatic L-amino acid decarboxylase (AADC) deficiency. AADC deficiency is a rare CNS disorder arising from reductions in the enzyme AADC that result from mutations in the dopa decarboxylase (DDC) gene. As of 2024, the AAV based treatment for AADC deficiency has been approved by the FDA and commercialized in the United States as Kebilidi. It is the first FDA-approved gene therapy treatment for AADC deficiency. This same product was granted EMA approval for use in the European Union under the name Upstaza.
Pipeline
In 2020, PTC acquired Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases, including phenylketonuria (PKU) and other diseases associated with defects in the tetrahydrobiopterin (BH4) biochemical pathways diagnosed at birth.
In 2020, PTC announced the FDA approval of Evrysdi (risdiplam) for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older.
In 2024, Novartis has committed $1 billion upfront in a licensing deal with PTC Therapeutics for an experimental treatment for Huntington’s disease, with the potential for an additional $1.9 billion tied to achieving specific development, regulatory, and commercial milestones. PTC Therapeutics’ therapy, known as PTC518, is an oral medication designed to reduce the production of the mutant protein linked to the genetic mutation responsible for the disease. This mutant protein is believed to contribute to neuronal death, driving disease progression. In June, interim data from a Phase 2 trial indicated that PTC518 successfully lowered levels of the mutant protein in both blood and cerebrospinal fluid.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
PTCT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$70.61
Piyasa Değeri
$5.75B
P/E (TTM)
9.1
EPS (TTM)
$7.78
Gelir (TTM)
$1.73B
Temettü Verimi
—
ROE
-331.5%
D/E Borç/Özsermaye
-1.4
52 Haftlık Aralık
$48 – $91
PTCT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$1.73B
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$7.78
2019-12-31
→
2025-12-31
Serbest Nakit Akışı
$702M
2016-12-31
→
2025-12-31
Marjlar
39.4%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
PTCT
Akran Ortalaması
P/E (TTM)
9.1
37.2
P/S (TTM) (F/S (TTM))
3.3
9.9
P/B (F/D)
-28.0
8.3
EV / EBITDA
4.5
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
8.2
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
PTCT
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
50.1%
—
Net Profit Margin (Net Kâr Marjı)
39.4%
-15.1%
ROA
29.7%
-23.3%
ROE
-331.5%
-30.6%
ROIC
1044.7%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
PTCT
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
-1.4
—
Current Ratio (Cari Oran)
2.3
6.3
Quick Ratio (Cari Oran)
2.2
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
PTCT
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
114.5%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
35.3%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
35.4%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
PTCT
Akran Ortalaması
PTCT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
21 analist
- Güçlü Al 6 28,6%
- Al 11 52,4%
- Tut 3 14,3%
- Sat 1 4,8%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
14 analist · 2026-08-20
Medyan
$100.00
Şimdi
$70.61
Düşük
$70.00
Yüksek
$130.00
Medyan hedef
$100.00
+41,6%
Ortalama hedef
$99.29
+40,6%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
1.9%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $0.92 | $0.43 | 0.49% |
| 31 Mart 2026 | $-0.03 | $-0.48 | 0.45% |
| 31 Aralık 2025 | $-1.67 | $0.04 | -1.7% |
| 30 Eylül 2025 | $0.20 | $-1.40 | 1.6% |
| 30 Haziran 2025 | $-0.83 | $-1.08 | 0.25% |
| 31 Mart 2025 | $10.04 | $-0.22 | 10.3% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| PBLS | — | — | — | — | — | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Cost of Revenue | · | · | · | · | · | · | $12M | $13M | $5M | $0 | $0 | · | |
| R&D Expense | $455M | $534M | $667M | $651M | $541M | $478M | $257M | $172M | $117M | $118M | $122M | $80M | |
| SG&A Expense | $347M | $301M | $333M | $326M | $286M | $245M | $203M | $154M | $121M | $97M | $82M | $45M | |
| Operating Expenses | $864M | $1.11B | $1.38B | $1.15B | $913M | $813M | $548M | $380M | $259M | $215M | $204M | $125M | |
| Operating Income | $867M | $-303M | $-440M | $-447M | $-374M | $-432M | $-241M | $-116M | $-64M | $-132M | $-167M | $-99M | |
| Other Non-op | $-18M | $7M | $10M | $-49M | $-58M | $85M | $14M | $129.0K | $-1M | $-1M | $-465.0K | $-213.0K | |
| Pretax Income | $697M | $-363M | $-696M | $-587M | $-518M | $-403M | $-240M | $-128M | $-78M | $-142M | $-170M | $-98M | |
| Income Tax | $14M | $176.0K | $-70M | $-28M | $6M | $35M | $12M | $-29.0K | $1M | $569.0K | $485.0K | $-5M | |
| Net Income | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| EPS (Basic) | $8.58 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | $-2.75 | $-2.02 | · | · | $-2.97 | |
| EPS (Diluted) | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 | $-6.64 | $-4.27 | · | · | · | · | $-2.97 | |
| Shares (Basic) | 79,534,290 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| Shares (Diluted) | 88,311,494 | 76,845,055 | 74,838,292 | 71,728,634 | 70,466,393 | 66,027,908 | 58,863,185 | · | · | · | · | 31,565,310 | |
| EBITDA | $906M | $-227M | $-203M | · | $-310M | $-388M | $-209M | $-90M | $-47M | $-132M | $-167M | $-99M |
Bilanço 27
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $985M | $780M | $594M | $280M | $190M | $209M | $288M | $169M | $112M | $58M | $58M | $50M | |
| Short-term Investments | $961M | $360M | $283M | $131M | $584M | $895M | $399M | $58M | $79M | $173M | $281M | $265M | |
| Receivables | $182M | $159M | $161M | $156M | $110M | $70M | $56M | $68M | $40M | $25M | $11M | $4M | |
| Inventory | $80M | $23M | $31M | $22M | $16M | $19M | $19M | $16M | $11M | $0 | · | · | |
| Prepaid Expense | $67M | $44M | $150M | $106M | $55M | $39M | $18M | $9M | $7M | $5M | $6M | $4M | |
| Current Assets | $2.27B | $1.37B | $1.22B | $694M | $954M | $1.23B | $779M | $321M | $249M | $261M | $356M | $324M | |
| PP&E (Net) | $55M | $61M | $87M | $73M | $53M | $34M | $22M | $13M | $8M | $7M | $9M | $9M | |
| PP&E (Gross) | $102M | $94M | $138M | $110M | $80M | $52M | $33M | $20M | $41M | $38M | $37M | $34M | |
| Accum. Depreciation | $47M | $33M | $51M | $37M | $27M | $18M | $12M | $7M | $33M | $31M | $28M | $25M | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $0 | · | · | · | |
| Intangibles | $389M | $119M | $379M | $706M | $725M | $715M | $710M | $701M | $133M | $0 | · | · | |
| Total Assets | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Accounts Payable | $45M | $17M | $6M | $27M | $23M | $19M | $10M | $6M | $15M | $6M | $6M | $4M | |
| Current Liabilities | $968M | $581M | $603M | $406M | $509M | $277M | $236M | $167M | $82M | $50M | $45M | $32M | |
| Capital Leases | $94M | $75M | $98M | $101M | $74M | $79M | $9M | · | · | · | · | · | |
| Deferred Tax | · | · | $56M | $103M | $137M | $137M | $131M | $122M | $0 | · | · | · | |
| Other Non-current Liabilities | $14M | $21M | $141.0K | $3M | · | $1M | $141.0K | $58.0K | $243.0K | $335.0K | $2M | $2M | |
| Total Liabilities | $3.10B | $2.80B | $2.71B | $2.05B | $1.94B | $1.73B | $1.03B | $768M | $235M | $150M | $139M | $35M | |
| Long-term Debt | · | · | · | · | $431M | · | $314M | $153M | $145M | · | · | · | |
| Total Debt | $287M | $285M | $284M | · | $431M | $309M | $314M | $153M | $145M | $98M | $95M | · | |
| Common Stock | $80.0K | $77.0K | $75.0K | $72.0K | $71.0K | $70.0K | $62.0K | $51.0K | $42.0K | $34.0K | $34.0K | $33.0K | |
| Paid-in Capital | $2.75B | $2.57B | $2.47B | $2.31B | $2.12B | $2.17B | $1.80B | $1.29B | $967M | $856M | $820M | $722M | |
| Retained Earnings | $-2.96B | $-3.65B | $-3.28B | $-2.66B | $-2.10B | $-1.63B | $-1.19B | $-939M | $-814M | $-735M | $-593M | $-423M | |
| AOCI | $11M | $-26M | $-1M | $5M | $-24M | $-61M | $-11M | $1M | $4M | $-1M | $-1M | $-737.0K | |
| Stockholders' Equity | $-205M | $-1.10B | $-819M | $-347M | $1M | $482M | $594M | $351M | $156M | $120M | $226M | $298M | |
| Liabilities + Equity | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $392M | $269M | $365M | $333M | |
| Shares Outstanding | 81,474,366 | 77,704,188 | 75,708,889 | 73,104,692 | 70,828,226 | 69,718,096 | 61,935,870 | 50,606,147 | 41,612,395 | 34,169,410 | 33,916,559 | 32,898,392 |
Nakit Akışı 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $39M | $76M | $237M | $129M | $64M | $43M | $32M | $26M | $18M | $3M | $3M | · | |
| Stock-based Comp | $75M | $75M | $102M | $110M | $104M | $70M | $42M | $33M | $31M | $35M | $34M | $19M | |
| Deferred Tax | $-3.0K | $-56M | $-47M | $-34M | $377.0K | $6M | $9M | $0 | $199.0K | $-199.0K | $0 | $0 | |
| Amort. of Intangibles | $25M | $61M | $223M | $117M | $55M | $37M | $28M | $23M | $15M | $0 | $0 | · | |
| Restructuring | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-85M | $161M | $177M | · | $105M | $124M | $70M | $41M | $20M | · | · | · | |
| Operating Cash Flow | $711M | $-108M | $-158M | $-357M | $-251M | $-194M | $-99M | $-28M | $-10M | $-104M | $-124M | $-57M | |
| CapEx | $9M | $7M | $28M | $32M | $28M | $18M | $14M | $7M | $3M | $2M | $3M | $5M | |
| Investing Cash Flow | $-862M | $44M | $-177M | $290M | $219M | $-562M | $-387M | $-43M | $13M | $104M | $-21M | $-145M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | $-49.0K | |
| Stock Issued | · | · | · | · | · | $28M | $324M | $118M | $0 | $0 | $0 | $236M | |
| Net Stock Activity | · | · | · | · | · | $28M | $324M | $118M | · | $0 | · | $236M | |
| Financing Cash Flow | $331M | $256M | $646M | $168M | $21M | $669M | $613M | $132M | $44M | $968.0K | $154M | $237M | |
| Net Change in Cash | $203M | $185M | $314M | $99M | $-19M | $-79M | $126M | $58M | $53M | $299.0K | $8M | $34M | |
| Taxes Paid | $37M | $18M | $14M | $5M | $8M | $26M | $2M | $2M | $1M | $943.0K | $111.0K | $0 | |
| Free Cash Flow | $702M | $-114M | $-187M | · | $-280M | $-212M | $-112M | $-35M | $-13M | $-105M | $-127M | $-62M |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 50.1% | -37.5% | -46.9% | · | -69.5% | -113.4% | -78.6% | -43.7% | -33.1% | -159.7% | -454.6% | -393.8% | |
| Net Margin | 39.4% | -45.0% | -66.8% | · | -97.3% | -115.1% | -82.0% | -48.4% | -40.6% | -171.8% | -463.6% | -371.4% | |
| Pretax Margin | 40.2% | -45.0% | -74.2% | · | -96.2% | -105.8% | -78.2% | -48.4% | -40.0% | -171.1% | -462.3% | -390.0% | |
| EBITDA Margin | 52.3% | -28.1% | -21.6% | · | -57.6% | -102.0% | -68.1% | -33.8% | -24.0% | -159.7% | -454.6% | -393.8% | |
| ROA | 29.7% | -20.2% | -34.8% | · | -25.3% | -22.9% | -18.3% | -17.0% | -23.9% | -44.8% | -48.6% | -38.6% | |
| ROE | -331.5% | 33.8% | 84.1% | · | -985.1% | -88.3% | -40.0% | -34.8% | -57.2% | -82.2% | -65.0% | -43.1% | |
| ROIC | 1044.7% | 37.2% | 74.0% | · | -87.4% | -59.4% | -27.8% | -23.0% | -21.7% | -60.9% | -52.3% | -31.7% |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.4 | 2.0 | · | 1.9 | 4.4 | 3.3 | 1.9 | 3.0 | 5.3 | 7.8 | 10.0 | |
| Quick Ratio | 2.2 | 2.2 | 1.7 | · | 1.7 | 4.2 | 3.1 | 1.8 | 2.8 | 5.2 | 7.7 | 9.8 | |
| Debt / Equity | -1.4 | -0.3 | -0.3 | · | 300.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · | |
| LT Debt / Equity | · | -0.3 | -0.3 | · | 196.0 | 0.6 | 0.5 | 0.4 | 0.9 | 0.8 | 0.4 | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.4 | 0.5 | · | 0.3 | 0.2 | 0.2 | 0.4 | 0.6 | 0.3 | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | 0.7 | · | 0.9 | · | · | · | |
| Receivables Turnover | 10.2 | 5.1 | 5.9 | · | 6.0 | 6.1 | 5.0 | 4.9 | 6.0 | 4.6 | 4.7 | 9.3 |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 114.5% | -14.0% | 34.2% | 29.8% | 41.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.3% | 14.4% | 35.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 35.4% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.73B | $807M | $938M | $699M | $539M | $381M | $307M | $265M | $194M | $83M | $37M | $25M | |
| Net Income TTM | $683M | $-363M | $-627M | $-559M | $-524M | $-438M | $-252M | $-128M | $-79M | $-142M | $-170M | $-94M | |
| Market Cap | $6.19B | $3.51B | $2.09B | · | $2.82B | $4.25B | $2.97B | $1.74B | $694M | $373M | $1.10B | $1.70B | |
| Enterprise Value | $4.53B | $2.65B | $1.49B | · | $2.48B | $3.46B | $2.60B | $1.66B | $648M | $239M | $855M | · | |
| P/E | 9.8 | -9.5 | -3.3 | -4.9 | -5.4 | -9.2 | -11.2 | -10.7 | -5.2 | -3.4 | -10.1 | -17.4 | |
| P/S | 3.6 | 4.3 | 2.2 | · | 5.2 | 11.2 | 9.7 | 6.6 | 3.6 | 4.5 | 29.9 | 67.5 | |
| P/B | -30.1 | -3.2 | -2.5 | · | 1961.8 | 8.8 | 5.0 | 5.0 | 4.4 | 3.1 | 4.9 | 5.7 | |
| P / Cash Flow | 8.7 | -32.6 | -13.2 | · | -11.2 | -21.9 | -30.2 | -62.8 | -69.0 | -3.6 | -8.8 | -29.7 | |
| P / FCF | 8.8 | -30.7 | -11.2 | · | -10.1 | -20.1 | -26.5 | -50.0 | -52.7 | -3.5 | -8.6 | -27.5 | |
| EV / EBITDA | 5.0 | -11.7 | -7.4 | · | -8.0 | -8.9 | -12.5 | -18.6 | -13.9 | -1.8 | -5.1 | · | |
| EV / FCF | 6.5 | -23.2 | -8.0 | · | -8.9 | -16.3 | -23.2 | -47.9 | -49.2 | -2.3 | -6.7 | · | |
| EV / Revenue | 2.6 | 3.3 | 1.6 | · | 4.6 | 9.1 | 8.5 | 6.3 | 3.3 | 2.9 | 23.2 | · | |
| Earnings Yield | 10.2% | -10.5% | -30.4% | -20.4% | -18.6% | -10.9% | -8.9% | -9.3% | -19.2% | -29.4% | -9.9% | -5.7% |
Gelir Tablosu 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $361M | $273M | $165M | $211M | $179M | $1.18B | $213M | $197M | $187M | $210M | $307M | $197M | $214M | $220M | $167M | $217M | |
| R&D Expense | $99M | $101M | $133M | $100M | $113M | $109M | $125M | $161M | $132M | $116M | $121M | $164M | $186M | $195M | $189M | $165M | |
| SG&A Expense | $81M | $86M | $97M | $84M | $85M | $81M | $85M | $73M | $70M | $73M | $76M | $81M | $88M | $87M | $93M | $80M | |
| Operating Expenses | $212M | $228M | $236M | $208M | $214M | $206M | $376M | $251M | $227M | $256M | $301M | $315M | $423M | $338M | $368M | $285M | |
| Operating Income | $149M | $45M | $-71M | $3M | $-35M | $970M | $-162M | $-55M | $-40M | $-45M | $6M | $-118M | $-210M | $-118M | $-200M | $-68M | |
| Other Non-op | $-3M | $2M | $-13M | $7M | $-6M | $-6M | $9M | $-2M | $-2M | $2M | $19M | $-20M | $1M | $10M | $35M | $-38M | |
| Pretax Income | $98M | $-2M | $-139M | $-23M | $-71M | $930M | $-95M | $-98M | $-86M | $-85M | $-157M | $-167M | $-237M | $-135M | $-190M | $-127M | |
| Income Tax | $14M | $347.0K | $-4M | $-39M | $-6M | $63M | $-29M | $9M | $13M | $7M | $-1M | $-34M | $-39M | $4M | $-19M | $-18M | |
| Net Income | $83M | $-3M | $-135M | $16M | $-65M | $867M | $-66M | $-107M | $-99M | $-92M | $-156M | $-133M | $-199M | $-139M | $-171M | $-109M | |
| EPS (Basic) | $1.01 | $-0.03 | $-1.88 | $0.20 | $-0.83 | $11.09 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| EPS (Diluted) | $0.92 | $-0.03 | $-1.63 | $0.20 | $-0.83 | $10.04 | $-0.85 | $-1.39 | $-1.29 | $-1.20 | $-2.07 | $-1.76 | $-2.66 | $-1.88 | $-2.35 | $-1.53 | |
| Shares (Basic) | 83,006,808 | 82,521,023 | -155,203,905 | 78,471,119 | 78,151,240 | 78,115,836 | -153,301,665 | 76,925,523 | 76,725,070 | 76,496,127 | -148,999,422 | 75,377,997 | 74,730,433 | 73,729,284 | -142,514,082 | 71,654,671 | |
| Shares (Diluted) | 92,020,009 | 82,521,023 | -163,341,037 | 87,115,369 | 78,151,240 | 86,385,922 | -153,301,665 | 76,925,523 | 76,725,070 | 76,496,127 | -148,999,422 | 75,377,997 | 74,730,433 | 73,729,284 | -142,514,082 | 71,654,671 | |
| EBITDA | $149M | $60M | · | $3M | $-35M | $977M | · | $-55M | $-40M | $10M | · | $-118M | $-210M | $-75M | · | $-68M |
Bilanço 27
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.05B | $834M | $985M | $673M | $1.02B | $1.48B | $780M | $526M | $655M | $548M | · | $165M | $208M | $167M | · | $104M | |
| Short-term Investments | $1.18B | $1.06B | $961M | $1.02B | $972M | $547M | $360M | $487M | $439M | $336M | · | $130M | $130M | $119M | · | $184M | |
| Receivables | $239M | $220M | $182M | $203M | $196M | $210M | $159M | $200M | $187M | $198M | · | $166M | $178M | $202M | · | $124M | |
| Inventory | $91M | $76M | $80M | $53M | $34M | $22M | $23M | $36M | $32M | $30M | · | $36M | $32M | $27M | · | $15M | |
| Prepaid Expense | $58M | $66M | $67M | $64M | $54M | $57M | $44M | $33M | $46M | $56M | · | $44M | $42M | $99M | · | $90M | |
| Current Assets | $2.62B | $2.25B | $2.27B | $2.01B | $2.27B | $2.32B | $1.37B | $1.28B | $1.36B | $1.17B | · | $540M | $590M | $613M | · | $517M | |
| PP&E (Net) | $51M | $53M | $55M | $57M | $57M | $59M | $61M | $63M | $66M | $93M | · | $85M | $82M | $79M | · | $67M | |
| PP&E (Gross) | · | · | $102M | · | · | · | $94M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | $82M | · | $82M | $82M | $82M | · | $82M | |
| Intangibles | $403M | $381M | $389M | $396M | $144M | $118M | $119M | $330M | $330M | $330M | · | $423M | $452M | $686M | · | $750M | |
| Total Assets | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Accounts Payable | $40M | $25M | $45M | $37M | $27M | $15M | $17M | $13M | $24M | $27M | · | $19M | $26M | $26M | · | $21M | |
| Current Liabilities | $771M | $924M | $968M | $866M | $628M | $595M | $581M | $611M | $610M | $575M | · | $492M | $476M | $442M | · | $420M | |
| Capital Leases | $88M | $90M | $94M | $95M | $71M | $74M | $75M | $83M | $79M | $105M | · | $100M | $100M | $100M | · | $102M | |
| Deferred Tax | · | · | · | · | · | · | · | $56M | $56M | $56M | · | $52M | $52M | $103M | · | $137M | |
| Other Non-current Liabilities | $15M | $14M | $14M | $3M | $8M | $22M | $21M | $77.0K | $141.0K | $141.0K | · | $141.0K | $141.0K | $141.0K | · | $5M | |
| Total Liabilities | $3.42B | $3.05B | $3.10B | $2.80B | $2.84B | $2.84B | $2.80B | $2.90B | $2.90B | $2.68B | · | $1.93B | $1.92B | $2.07B | · | $1.80B | |
| Long-term Debt | $591M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $591M | $287M | · | $286M | $286M | $286M | · | $285M | $285M | $285M | · | $573M | $573M | $572M | · | $283M | |
| Common Stock | $82.0K | $81.0K | $80.0K | $79.0K | $78.0K | $78.0K | $77.0K | $76.0K | $76.0K | $76.0K | · | $75.0K | $75.0K | $73.0K | · | $71.0K | |
| Paid-in Capital | $2.71B | $2.78B | $2.75B | $2.67B | $2.63B | $2.61B | $2.57B | $2.53B | $2.51B | $2.49B | · | $2.45B | $2.42B | $2.34B | · | $2.22B | |
| Retained Earnings | $-2.88B | $-2.97B | $-2.96B | $-2.83B | $-2.85B | $-2.78B | $-3.65B | $-3.58B | $-3.47B | $-3.38B | · | $-3.13B | $-2.99B | $-2.80B | · | $-2.49B | |
| AOCI | $6M | $8M | $11M | $6M | $7M | $-14M | $-26M | $-4M | $-16M | $-6M | · | $10M | $-1M | $-2M | · | $36M | |
| Stockholders' Equity | $-165M | $-180M | $-205M | $-156M | $-207M | $-186M | $-1.10B | $-1.05B | $-980M | $-894M | $-819M | $-671M | $-579M | $-458M | $-347M | $-227M | |
| Liabilities + Equity | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | · | $1.26B | $1.34B | $1.61B | · | $1.58B | |
| Shares Outstanding | 83,327,286 | 82,882,024 | 81,474,366 | 79,931,766 | 79,378,145 | 79,225,276 | 77,704,188 | 76,952,124 | 76,900,123 | 76,653,960 | · | 75,459,022 | 75,318,233 | 74,012,034 | · | 71,854,892 |
Nakit Akışı 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $15M | $13M | $11M | $8M | $7M | $7M | $6M | $7M | $55M | $81M | $62M | $51M | $43M | $39M | $34M | |
| Stock-based Comp | $23M | $23M | $19M | $19M | $19M | $18M | $17M | $20M | $19M | $18M | $17M | $27M | $29M | $29M | $27M | $29M | |
| Deferred Tax | · | $-10.0K | $1.0K | · | · | $2.0K | $-56M | $-3.0K | $2.0K | $-1.0K | $4M | $-2.0K | $-51M | $-4.0K | · | · | |
| Amort. of Intangibles | $12M | $12M | $9M | $8M | $4M | $4M | $3M | $3M | $3M | $52M | $77M | $59M | $47M | $39M | $36M | $31M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $23M | $8M | · | · | · | |
| Other Non-cash | · | $-95M | · | · | · | $-22M | · | · | · | $89M | · | · | · | $38M | · | · | |
| Operating Cash Flow | $129M | $-59M | $-34M | $-66M | $-58M | $870M | $-30M | $-77M | $-71M | $71M | $-100M | $-15M | $-14M | $-29M | $-166M | $-38M | |
| CapEx | $2M | $1M | $2M | $3M | $1M | $2M | $4M | $522.0K | $-7M | $10M | $6M | $6M | $6M | $10M | $9M | $5M | |
| Investing Cash Flow | $-123M | $-94M | $34M | $-290M | $-422M | $-184M | $268M | $-43M | $-66M | $-115M | $-94M | $-30M | $-24M | $-29M | $32M | $136M | |
| Financing Cash Flow | $212M | $6M | $303M | $15M | $4M | $9M | $26M | $-18M | $246M | $540.0K | $620M | $3M | $18M | $4M | $303M | $-140M | |
| Net Change in Cash | $216M | $-148M | $312M | $-347M | $-463M | $701M | $256M | $-129M | $104M | $-46M | $429M | $-43M | $-9M | $-62M | $175M | $-54M | |
| Taxes Paid | · | · | $-3M | $936.0K | $36M | $3M | $5M | $7M | $4M | $2M | $524.0K | $4M | $7M | $2M | $893.0K | $1M | |
| Free Cash Flow | · | $-60M | · | · | · | $868M | · | · | · | $61M | · | · | · | $-40M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.3% | 16.5% | · | 1.4% | -19.5% | 82.5% | · | -27.7% | -21.5% | -21.6% | · | -60.1% | -98.0% | -53.4% | · | -31.4% | |
| Net Margin | 23.2% | -1.0% | · | 7.5% | -36.2% | 73.7% | · | -54.2% | -53.1% | -43.6% | · | -67.6% | -93.0% | -63.0% | · | -50.3% | |
| Pretax Margin | 27.1% | -0.90% | · | -10.9% | -39.7% | 79.1% | · | -49.8% | -45.9% | -40.3% | · | -84.8% | -111.1% | -61.3% | · | -58.6% | |
| EBITDA Margin | 41.3% | 22.1% | · | 1.4% | -19.5% | 83.1% | · | -27.7% | -21.5% | 4.7% | · | -60.1% | -98.0% | -33.9% | · | -31.4% | |
| ROA | 2.8% | -0.10% | · | 0.71% | -2.9% | 39.0% | · | -6.9% | -6.1% | -5.4% | · | -9.4% | -12.7% | -8.2% | · | -6.1% | |
| ROE | -44.9% | 1.5% | · | -2.6% | 10.9% | -160.5% | · | 12.4% | 12.7% | 13.6% | · | 29.6% | 52.2% | 50.7% | · | 179.2% | |
| ROIC | 30.0% | 48.2% | · | -1.6% | -40.2% | 904.6% | · | 7.7% | 6.7% | 8.1% | · | 96.6% | 2648.9% | -105.7% | · | -104.9% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.4 | · | 2.3 | 3.6 | 3.9 | · | 2.1 | 2.2 | 2.0 | · | 1.1 | 1.2 | 1.4 | · | 1.2 | |
| Quick Ratio | 3.2 | 2.3 | · | 2.2 | 3.5 | 3.8 | · | 2.0 | 2.1 | 1.9 | · | 0.9 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | -3.6 | -1.6 | · | -1.8 | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 | |
| LT Debt / Equity | -3.2 | · | · | · | -1.4 | -1.5 | · | -0.3 | -0.3 | -0.3 | · | -0.9 | -1.0 | -1.3 | · | -1.2 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.5 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.7 | 1.3 | · | 1.0 | 0.9 | 5.8 | · | 1.1 | 1.0 | 1.1 | · | 1.4 | 1.4 | 1.3 | · | 2.0 |
Değerleme (TTM) 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.02B | $1.84B | · | $1.76B | $1.74B | $1.77B | · | $790M | $807M | $841M | · | $848M | $817M | $752M | · | $670M | |
| Net Income TTM | $32M | $815M | · | $711M | $596M | $569M | · | $-430M | $-523M | $-562M | · | $-580M | $-599M | $-527M | · | $-522M | |
| Market Cap | $6.80B | $5.65B | · | $4.91B | $3.88B | $4.04B | · | $2.85B | $2.35B | $2.23B | · | $1.69B | $3.06B | $3.59B | · | $3.61B | |
| Enterprise Value | $5.16B | $4.04B | · | $3.50B | $2.17B | $2.30B | · | $2.13B | $1.54B | $1.63B | · | $1.97B | $3.30B | $3.87B | · | $3.60B | |
| P/E | 313.7 | 7.3 | · | 7.7 | 7.5 | 8.3 | · | -6.6 | -4.4 | -3.9 | · | -2.9 | -5.0 | -6.6 | · | -6.8 | |
| P/S | 6.6 | 3.1 | · | 2.8 | 2.2 | 2.3 | · | 3.6 | 2.9 | 2.7 | · | 2.0 | 3.8 | 4.8 | · | 5.4 | |
| P/B | -41.1 | -31.3 | · | -31.5 | -18.8 | -21.7 | · | -2.7 | -2.4 | -2.5 | · | -2.5 | -5.3 | -7.8 | · | -15.9 | |
| P / Cash Flow | · | -95.6 | · | · | · | 4.6 | · | · | · | 31.5 | · | · | · | -121.6 | · | · | |
| P / FCF | · | -93.7 | · | · | · | 4.6 | · | · | · | 36.5 | · | · | · | -90.2 | · | · | |
| EV / EBITDA | 34.6 | 66.9 | · | 1161.8 | -62.2 | 2.3 | · | -39.0 | -38.4 | 163.9 | · | -16.7 | -15.7 | -51.8 | · | -52.8 | |
| EV / FCF | · | -67.1 | · | · | · | 2.6 | · | · | · | 26.6 | · | · | · | -97.4 | · | · | |
| EV / Revenue | 5.0 | 2.2 | · | 2.0 | 1.3 | 1.3 | · | 2.7 | 1.9 | 1.9 | · | 2.3 | 4.0 | 5.1 | · | 5.4 | |
| Earnings Yield | 0.32% | 13.8% | · | 13.1% | 13.4% | 12.1% | · | -15.2% | -22.6% | -25.8% | · | -34.9% | -20.2% | -15.1% | · | -14.6% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $1.73B | $807M | $938M | $699M | $539M |
| Faaliyet Kâr Marjı % | 50.1% | -37.5% | -46.9% | — | -69.5% |
| Net Gelir | $683M | $-363M | $-627M | $-559M | $-524M |
| Seyreltilmiş Hisse Başı Kâr | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -1.4 | -0.3 | -0.3 | — | 300.0 |
| Cari Oran | 2.3 | 2.4 | 2.0 | — | 1.9 |
| Cari Oran | 2.2 | 2.2 | 1.7 | — | 1.7 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $702M | $-114M | $-187M | — | $-280M |
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 405 dosya · $5.4B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 77 (+10 önceki Ç'ye göre) | 43 (-7 önceki Ç'ye göre) | 137 (-2 önceki Ç'ye göre) | 111 (+8 önceki Ç'ye göre) | -7.1M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $631.875.072 | 7.746.415 | 11,70% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $479.178.655 | 7.034.622 | 8,87% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $401.986.014 | 4.928.111 | 7,44% | Hisse senetleri |
| STATE STREET CORP | $375.136.515 | 4.598.952 | 6,95% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $305.000.589 | 3.739.127 | 5,65% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $292.435.873 | 3.585.091 | 5,42% | Hisse senetleri |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $159.563.645 | 1.956.156 | 2,95% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $155.132.041 | 1.901.417 | 2,87% | Hisse senetleri |
| Hood River Capital Management LLC | $141.818.662 | 1.738.613 | 2,63% | Hisse senetleri |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $140.519.660 | 1.722.688 | 2,60% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $122.355.000 | 1.500.000 | 2,27% | Hisse senetleri |
| Driehaus Capital Management LLC | $117.469.528 | 1.440.107 | 2,18% | Hisse senetleri |
| Jefferies Financial Group Inc. | $110.693.916 | 1.357.042 | 2,05% | Hisse senetleri |
| FULLER & THALER ASSET MANAGEMENT, INC. | $94.361.749 | 1.156.819 | 1,75% | Hisse senetleri |
| Pictet Asset Management Holding SA | $93.629.635 | 1.147.844 | 1,73% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $87.393.690 | 1.071.395 | 1,62% | Hisse senetleri |
| Blue Sparrow, LLC /DE | $85.705.599 | 1.050.700 | 1,59% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $77.478.857 | 949.845 | 1,43% | Hisse senetleri |
| Palo Alto Investors LP | $74.950.268 | 918.846 | 1,39% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $64.449.436 | 790.112 | 1,19% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $59.015.895 | 723.500 | 1,09% | Hisse senetleri |
| Boston Partners | $57.080.953 | 699.871 | 1,06% | Hisse senetleri |
| FMR LLC | $56.956.987 | 698.259 | 1,05% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $56.350.840 | 690.828 | 1,04% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $53.377.940 | 654.382 | 0,99% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $51.486.821 | 631.199 | 0,95% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $47.953.943 | 587.887 | 0,89% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $41.442.128 | 508.056 | 0,77% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $40.866.277 | 500.995 | 0,76% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $36.050.432 | 441.957 | 0,67% | Hisse senetleri |
| Parkman Healthcare Partners LLC | $35.539.315 | 435.691 | 0,66% | Hisse senetleri |
| LOOMIS SAYLES & CO L P | $35.387.921 | 433.835 | 0,66% | Hisse senetleri |
| Defilade Capital Management, L.P. | $35.376.827 | 433.699 | 0,66% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $34.153.522 | 418.702 | 0,63% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $32.274.149 | 395.662 | 0,60% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $30.892.190 | 378.720 | 0,57% | Hisse senetleri |
| Qube Research & Technologies Ltd | $25.398.777 | 311.374 | 0,47% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $24.471.000 | 300.000 | 0,45% | Alım opsiyonu |
| Public Sector Pension Investment Board | $23.249.326 | 285.023 | 0,43% | Hisse senetleri |
| SEGALL BRYANT & HAMILL, LLC | $22.165.424 | 271.735 | 0,41% | Hisse senetleri |
| CITADEL ADVISORS LLC | $20.338.011 | 249.332 | 0,38% | Hisse senetleri |
| MORGAN STANLEY | $18.990.210 | 232.808 | 0,35% | Hisse senetleri |
| Boxer Capital Management, LLC | $16.314.000 | 200.000 | 0,30% | Hisse senetleri |
| RHUMBLINE ADVISERS | $15.718.994 | 192.706 | 0,29% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $13.904.178 | 170.457 | 0,26% | Hisse senetleri |
| PRUDENTIAL FINANCIAL INC | $13.746.176 | 168.520 | 0,25% | Hisse senetleri |
| BlackRock, Inc. | $13.589.562 | 166.600 | 0,25% | Hisse senetleri |
| Rock Springs Capital Management LP | $13.238.648 | 162.298 | 0,25% | Hisse senetleri |
| Hudson Bay Capital Management LP | $13.033.091 | 159.778 | 0,24% | Hisse senetleri |
| Russell Investments Group, Ltd. | $12.687.724 | 155.544 | 0,23% | Hisse senetleri |
| Schonfeld Strategic Advisors LLC | $12.025.457 | 147.425 | 0,22% | Hisse senetleri |
| MARSHALL WACE, LLP | $11.724.301 | 143.733 | 0,22% | Hisse senetleri |
| Swiss National Bank | $11.539.300 | 141.465 | 0,21% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $11.063.583 | 135.633 | 0,20% | Hisse senetleri |
| Legal & General Group Plc | $10.362.979 | 127.044 | 0,19% | Hisse senetleri |
| CITIGROUP INC | $9.272.143 | 113.671 | 0,17% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $9.246.285 | 113.354 | 0,17% | Hisse senetleri |
| Longaeva Partners L.P. | $9.119.771 | 111.803 | 0,17% | Hisse senetleri |
| JUPITER ASSET MANAGEMENT LTD | $8.927.184 | 109.442 | 0,17% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $8.215.404 | 100.716 | 0,15% | Hisse senetleri |
| SECTOR GAMMA AS | $8.157.000 | 100.000 | 0,15% | Hisse senetleri |
| WCM INVESTMENT MANAGEMENT, LLC | $7.651.184 | 93.799 | 0,14% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $7.256.141 | 88.956 | 0,13% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $7.239.501 | 88.752 | 0,13% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $7.217.488 | 105.937 | 0,13% | Hisse senetleri |
| Aquatic Capital Management LLC | $6.808.648 | 83.470 | 0,13% | Hisse senetleri |
| XTX Topco Ltd | $6.682.459 | 81.923 | 0,12% | Hisse senetleri |
| MOORE CAPITAL MANAGEMENT, LP | $6.165.713 | 75.588 | 0,11% | Hisse senetleri |
| PINNACLE ASSOCIATES LTD | $5.745.383 | 70.435 | 0,11% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $5.744.722 | 84.320 | 0,11% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $5.614.300 | 68.828 | 0,10% | Hisse senetleri |
| Capricorn Fund Managers Ltd | $5.212.323 | 63.900 | 0,10% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.000.241 | 61.300 | 0,09% | Alım opsiyonu |
| INTECH INVESTMENT MANAGEMENT LLC | $4.696.882 | 57.581 | 0,09% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $4.672.166 | 57.278 | 0,09% | Hisse senetleri |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $4.561.884 | 55.926 | 0,08% | Hisse senetleri |
| BARCLAYS PLC | $4.169.858 | 51.120 | 0,08% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $4.005.087 | 49.100 | 0,07% | Hisse senetleri |
| MetLife Investment Management, LLC | $3.932.653 | 48.212 | 0,07% | Hisse senetleri |
| Point72 Europe (London) LLP | $3.829.919 | 62.407 | 0,07% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $3.792.516 | 46.494 | 0,07% | Hisse senetleri |
| Phocas Financial Corp. | $3.766.087 | 46.170 | 0,07% | Hisse senetleri |
| MARTINGALE ASSET MANAGEMENT L P | $3.627.826 | 44.475 | 0,07% | Hisse senetleri |
| Quadrature Capital Ltd | $3.589.488 | 44.005 | 0,07% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.531.981 | 43.300 | 0,07% | Satım opsiyonu |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.436.299 | 42.127 | 0,06% | Hisse senetleri |
| CREDIT AGRICOLE S A | $3.344.370 | 41.000 | 0,06% | Hisse senetleri |
| Fisher Asset Management, LLC | $3.322.345 | 40.730 | 0,06% | Hisse senetleri |
| HSBC HOLDINGS PLC | $3.200.425 | 38.732 | 0,06% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $3.134.490 | 38.427 | 0,06% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $3.114.179 | 38.178 | 0,06% | Hisse senetleri |
| CenterBook Partners LP | $3.082.938 | 37.795 | 0,06% | Hisse senetleri |
| Rafferty Asset Management, LLC | $3.069.805 | 37.634 | 0,06% | Hisse senetleri |
| FIFTH THIRD BANCORP | $3.044.843 | 37.328 | 0,06% | Hisse senetleri |
| BURNEY CO/ | $3.044.192 | 37.320 | 0,06% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $3.033.180 | 37.185 | 0,06% | Hisse senetleri |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | $3.007.731 | 36.873 | 0,06% | Hisse senetleri |
| Louisiana State Employees Retirement System | $2.969.148 | 36.400 | 0,05% | Hisse senetleri |
| JANE STREET GROUP, LLC | $2.854.950 | 35.000 | 0,05% | Satım opsiyonu |
| CASTLEARK MANAGEMENT LLC | $2.765.223 | 33.900 | 0,05% | Hisse senetleri |
Şirket yöneticileri 36 içeriden öğrenenler · 14 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Stuart Walter Peltz | CHIEF EXECUTIVE OFFICER | 31 Ocak 2023 S | 54.903 | 0 | 0 | $0 |
| Pierre Gravier | CHIEF FINANCIAL OFFICER | 14 Temmuz 2026 S | 83.986 | 0 | 1 | $-280.743 |
| Emily Luisa Hill | CHIEF FINANCIAL OFFICER | 27 Mart 2023 S | 38.925 | 0 | 0 | $0 |
| Shane William Charles Kovacs | Chief Financial Officer | 09 Mayıs 2017 M | 37.850 | 0 | 0 | $0 |
| Claudia De Oliveira Ribeiro Hirawat | President | 15 Ocak 2015 M | 39.247 | 0 | 0 | $0 |
| Marcio Souza | Chief Operating Officer | 10 Şubat 2020 M | 6.744 | 0 | 0 | $0 |
| Mark Elliott Boulding | EXEC. VP AND CLO | 17 Ağustos 2026 M | 105.272 | 0 | 14 | $-1.459.113 |
| Neil Gregory Almstead | CHIEF TECHNICAL OPS OFFICER | 09 Temmuz 2026 M | 60.299 | 0 | 20 | $-9.184.852 |
| Christine Marie Utter | SVP, CHIEF ACCOUNTING OFFICER | 17 Haziran 2026 M | 70.199 | 0 | 1 | $-1.487.474 |
| Eric Pauwels | CHIEF BUSINESS OFFICER | 10 Haziran 2026 S | 73.411 | 0 | 28 | $-7.477.160 |
| Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | 07 Mayıs 2024 S | 59.813 | 0 | 0 | $0 |
| Mark Rothera | Chief Commercial Officer | 24 Mayıs 2017 M | 33.739 | 0 | 0 | $0 |
| Tuyen Ong | Chief Medical Officer | 03 Ocak 2017 A | 6.000 | 0 | 0 | $0 |
| Robert J. Spiegel | Chief Medical Officer | 04 Ocak 2016 A | 3.239 | 0 | 0 | $0 |
| Hege Elisabeth Sollie-Zetlmayer | Yönetim kurulu üyesi | 28 Temmuz 2026 A | 52.526 | 0 | 0 | $0 |
| Mary L. Smith | Yönetim kurulu üyesi | 09 Temmuz 2026 M | 21.813 | 0 | 2 | $-1.425.060 |
| Jerome B Zeldis | Yönetim kurulu üyesi | 02 Aralık 2024 M | 14.500 | 0 | 0 | $0 |
| William F. Bell Jr. | Yönetim kurulu üyesi | 15 Şubat 2024 A | 10.333 | 0 | 0 | $0 |
| Alethia Young | Yönetim kurulu üyesi | 15 Şubat 2024 A | 13.067 | 0 | 0 | $0 |
| Stephanie Okey | Yönetim kurulu üyesi | 15 Şubat 2024 A | 9.867 | 0 | 0 | $0 |
| Emma Reeve | Yönetim kurulu üyesi | 15 Şubat 2024 A | 11.200 | 0 | 0 | $0 |
| Allan Steven Jacobson | Yönetim kurulu üyesi | 15 Şubat 2024 A | 16.348 | 0 | 0 | $0 |
| Dawn Svoronos | Yönetim kurulu üyesi | 09 Haziran 2022 S | 29.017 | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | Yönetim kurulu üyesi | 03 Ocak 2017 A | — | 0 | 0 | $0 |
| Adam Koppel | Yönetim kurulu üyesi | 03 Ocak 2017 A | 2.333.333 | 0 | 0 | $0 |
| Ronald C Renaud JR | Yönetim kurulu üyesi | 03 Ocak 2017 A | — | 0 | 0 | $0 |
| Richard Aldrich | Yönetim kurulu üyesi | 08 Haziran 2015 M | 0 | 0 | 0 | $0 |
| Michael L Kranda | Yönetim kurulu üyesi | 16 Mart 2015 S | 2.242 | 0 | 0 | $0 |
| Axel Bolte | Yönetim kurulu üyesi | 25 Haziran 2013 P | 20.000 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% sahip | 17 Aralık 2013 S | 2.441.504 | 0 | 0 | $0 |
| Matthew B. Klein | — | 04 Ağustos 2026 S | 383.868 | 0 | 1 | $-705.722 |
| Michael Schmertzler | — | 02 Ocak 2026 A | 163.266 | 0 | 0 | $0 |
| Glenn Steele JR MD PHD | — | 02 Ocak 2026 A | 22.500 | 0 | 1 | $-916.200 |
| David P Southwell | — | 02 Ocak 2026 A | 20.850 | 0 | 0 | $0 |
| Complete Pharma Holdings II, LLC | — | 28 Nisan 2017 J | 0 | 0 | 0 | $0 |
| CREDIT SUISSE/ | — | 25 Haziran 2013 C | 2.256.882 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Brookside Capital Partners Fund, L.P., Brookside Capital Trading Fund, L.P. ×5 başvurular | 30 Ocak 2015 | — | İlk başvuru | — | SEC |
| HBM Healthcare Investments (Cayman) Ltd. (“HBM”) ×2 başvurular | 12 Kasım 2014 | — | İlk başvuru | — | SEC |
| HBM Healthcare Investments (Cayman) Ltd. | 05 Temmuz 2013 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 88 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IBRN · iShares Trust | 3,78% | 4.145 SH | 19 Ağustos 2026 | Günlük |
| PSCH · Invesco Exchange-Traded Fund Trust … | 3,04% | 77.998 SH | 19 Ağustos 2026 | Günlük |
| PBE · Invesco Exchange-Traded Fund Trust | 2,51% | 134.138 SH | 19 Ağustos 2026 | Günlük |
| XSMO · Invesco Exchange-Traded Fund Trust | 1,52% | 644.768 SH | 19 Ağustos 2026 | Günlük |
| BBP · ETFis Series Trust I | 1,37% | 12.510 NS | 30 Nisan 2026 | N-PORT |
| SIXS · EXCHANGE TRADED CONCEPTS TRUST | 1,30% | 22.380 NS | 31 Mayıs 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1,25% | 23.422 SH | 19 Ağustos 2026 | Günlük |
| GURU · Global X Funds | 1,03% | 9.268 NS | 30 Nisan 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 73.928 NS | 30 Nisan 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 0,83% | 10.625 NS | 30 Nisan 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,74% | 98.733 SH | 19 Ağustos 2026 | Günlük |
| VMAX · Lattice Strategies Trust | 0,72% | 5.120 NS | 30 Nisan 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,51% | 40.257 NS | 30 Nisan 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,49% | 3.490 NS | 31 Mayıs 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0,49% | 40.488 NS | 31 Mayıs 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,47% | 135.289 NS | 30 Haziran 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0,43% | 3.203 NS | 30 Nisan 2026 | N-PORT |
| IBB · iShares Trust | 0,42% | 594.562 SH | 19 Ağustos 2026 | Günlük |
| OASC · Unified Series Trust | 0,40% | 4.569 NS | 31 Mayıs 2026 | N-PORT |
| BRNY · EA Series Trust | 0,40% | 34.057 NS | 30 Nisan 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,40% | 4.590 SH | 19 Ağustos 2026 | Günlük |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,37% | 290.018 SH | 19 Ağustos 2026 | Günlük |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,34% | 35.034 NS | 31 Mayıs 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,34% | 75.795 SH | 19 Ağustos 2026 | Günlük |
| ESSC · Strategy Shares | 0,34% | 1.335 NS | 30 Nisan 2026 | N-PORT |
| IWO · iShares Trust | 0,31% | 643.797 SH | 19 Ağustos 2026 | Günlük |
| BIB · ProShares Trust | 0,31% | 3.062 NS | 31 Mayıs 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,31% | 11.451 NS | 31 Mayıs 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,30% | 39.411 NS | 31 Mayıs 2026 | N-PORT |
| SAA · ProShares Trust | 0,26% | 961 NS | 31 Mayıs 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,25% | 22.443 NS | 30 Nisan 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 27.276 NS | 30 Nisan 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,23% | 2.877 NS | 30 Nisan 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,23% | 3.003 NS | 31 Mayıs 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,20% | 477.030 SH | 19 Ağustos 2026 | Günlük |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,20% | 39.967 NS | 30 Nisan 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,19% | 1.099.640 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,19% | 2.121.268 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,18% | 72.565 SH | 19 Ağustos 2026 | Günlük |
| LRGF · iShares Trust | 0,17% | 84.240 SH | 19 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,16% | 22.792 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,16% | 34.125 NS | 30 Nisan 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 11.071 NS | 30 Nisan 2026 | N-PORT |
| ITWO · ProShares Trust | 0,15% | 3.710 NS | 31 Mayıs 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 35.428 SH | 19 Ağustos 2026 | Günlük |
| FSMD · FIDELITY COVINGTON TRUST | 0,14% | 49.932 NS | 30 Nisan 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,14% | 5.350 SH | 19 Ağustos 2026 | Günlük |
| SMDX · Tidal Trust III | 0,13% | 2.579 NS | 30 Nisan 2026 | N-PORT |
| SXQG · EXCHANGE TRADED CONCEPTS TRUST | 0,13% | 1.182 NS | 31 Mayıs 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,13% | 386.068 NS | 31 Mayıs 2026 | N-PORT |